BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10669626)

  • 1. Warfarin-induced artery calcification is accelerated by growth and vitamin D.
    Price PA; Faus SA; Williamson MK
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):317-27. PubMed ID: 10669626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
    Price PA; Faus SA; Williamson MK
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):817-24. PubMed ID: 11348880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D.
    Price PA; June HH; Buckley JR; Williamson MK
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1610-6. PubMed ID: 11597934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves.
    Price PA; Faus SA; Williamson MK
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1400-7. PubMed ID: 9743228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats.
    Price PA; Buckley JR; Williamson MK
    J Nutr; 2001 Nov; 131(11):2910-5. PubMed ID: 11694617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function.
    Fusaro M; Dalle Carbonare L; Dusso A; Arcidiacono MV; Valenti MT; Aghi A; Pasho S; Gallieni M
    PLoS One; 2015; 10(8):e0133847. PubMed ID: 26241483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin induces cardiovascular damage in mice.
    Krüger T; Oelenberg S; Kaesler N; Schurgers LJ; van de Sandt AM; Boor P; Schlieper G; Brandenburg VM; Fekete BC; Veulemans V; Ketteler M; Vermeer C; Jahnen-Dechent W; Floege J; Westenfeld R
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2618-24. PubMed ID: 23990204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.
    McCabe KM; Booth SL; Fu X; Shobeiri N; Pang JJ; Adams MA; Holden RM
    Kidney Int; 2013 May; 83(5):835-44. PubMed ID: 23344475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats.
    Schurgers LJ; Spronk HM; Soute BA; Schiffers PM; DeMey JG; Vermeer C
    Blood; 2007 Apr; 109(7):2823-31. PubMed ID: 17138823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of age on vascular calcification induced by vitamin D3 and nicotine].
    Shi Y; Zhou YB; Cai Y; Teng X; Song JQ; Duan XH; Zhang WZ; Qi YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):131-6. PubMed ID: 20396349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K2 regression aortic calcification induced by warfarin via Gas6/Axl survival pathway in rats.
    Jiang X; Tao H; Qiu C; Ma X; Li S; Guo X; Lv A; Li H
    Eur J Pharmacol; 2016 Sep; 786():10-18. PubMed ID: 27212383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption.
    Price PA; Omid N; Than TN; Williamson MK
    Calcif Tissue Int; 2002 Oct; 71(4):356-63. PubMed ID: 12183764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Model of Subclinical Vitamin K Deficiency.
    Gancheva S; Kitanova M; Ghenev P; Zhelyazkova-Savova M
    Folia Med (Plovdiv); 2020 Jun; 62(2):378-384. PubMed ID: 32666757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE-/- mice.
    Rattazzi M; Faggin E; Bertacco E; Nardin C; Pagliani L; Plebani M; Cinetto F; Guidolin D; Puato M; Pauletto P
    Cardiovasc Ther; 2018 Aug; 36(4):e12438. PubMed ID: 29847020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.
    Lomashvili KA; Wang X; Wallin R; O'Neill WC
    J Biol Chem; 2011 Aug; 286(33):28715-28722. PubMed ID: 21705322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of vitamin D analogs on vascular calcification.
    Cardús A; Panizo S; Parisi E; Fernandez E; Valdivielso JM
    J Bone Miner Res; 2007 Jun; 22(6):860-6. PubMed ID: 17352647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells--a cell system which resembles the system in bone cells.
    Wallin R; Cain D; Sane DC
    Thromb Haemost; 1999 Dec; 82(6):1764-7. PubMed ID: 10613667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K-dependent proteins, warfarin, and vascular calcification.
    Danziger J
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1504-10. PubMed ID: 18495950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment.
    Essalihi R; Dao HH; Yamaguchi N; Moreau P
    Am J Hypertens; 2003 Feb; 16(2):103-10. PubMed ID: 12559675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural study of hypervitaminosis D induced arterial calcification in Wistar rats.
    Kingma JG; Roy PE
    Artery; 1988; 16(1):51-61. PubMed ID: 3207390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.